Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-490x|23|1|62-70

ISSN： 1083-7159

Source： The Oncologist, Vol.23, Iss.1, 2018-01, pp. : 62-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma

By Schöffski Patrick   Wolter Pascal   Clement Paul   Sciot Raf   De Wever Ivo   Wozniak Agnieszka   Stefan Cristiana   Dumez Herlinde  

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 381-392

Future Medicine

Access to resources Recommend Favorite

Alveolar soft part sarcoma - a report of 15 cases

By van Ruth S.   van Coevorden F.   Peterse J.L.   Kroon B.B.R.  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1324-1328

Elsevier

Access to resources Recommend Favorite

Alveolar soft part sarcoma: Clinicopathological analysis and imaging results

By          

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2777-2780

Spandidos Publications

Access to resources Recommend Favorite

Pazopanib for the Treatment of Soft Tissue Sarcoma – Where Does It Fit?

By Mallick Atrayee Basu   Narasimhan Vivek   Soman Neelesh   Chawla Sant P  

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 59-63

Optimal Clinical Ltd

Access to resources Recommend Favorite

Alveolar Soft Part Sarcoma: Clinical Presentation, Treatment, and Outcome in a Series of 33 Patients at a Single Institution

By Pennacchioli Elisabetta  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3229-3233

Springer Publishing Company

Access to resources Recommend Favorite